ArticleViruses2023

Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study.

Vassiliki Spiliopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.